2 results
Approved WMOPending
Determine feasibility and reliability of CDFM in relation to the current strategy of intermittent Doppler US examinations for detection of hepatic artery thrombosis.
Approved WMOPending
The primary objective is to determine the safety, tolerability, dose-limiting toxicities (DLTs), and maximum tolerated dose (MTD)/recommended Phase 2 dose (RP2D) of BMS-986178 administered alone or in combination with nivolumab and/or ipilimumab in…